01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $58.94B
1 older move runs past ±150% (largest +177.5%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $58.94B | −2.3% | 10-K | |
| FY2024 | $60.34B | +15.6% | 10-K | |
| FY2023 | $52.19B | −11.7% | 10-K | |
| FY2022 | $59.13B | −7.9% | 10-K | |
| FY2021 | $64.19B | −17.2% | 10-K | |
| FY2020 | $77.55B | +23.2% | 10-K | |
| FY2019 | $62.98B | +79.9% | 10-K | |
| FY2018 | $35.00B | +13.1% | 10-K | |
| FY2017 | $30.95B | −15.1% | 10-K | |
| FY2016 | $36.44B | +24.6% | 10-K | |
| FY2015 | $29.24B | +177.5% | 10-K | |
| FY2014 | $10.54B | −26.3% | 10-K | |
| FY2013 | $14.29B | −2.3% | 10-K | |
| FY2012 | $14.63B | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is AbbVie Inc.'s current long-term debt?
AbbVie Inc. (ABBV) annual long-term debt for 2025 was $58.94B, a 2.32% decline from 2024. AbbVie Inc. long-term debt for the quarter ending March 31, 2026 was $64.53B.
What was AbbVie Inc.'s long-term debt in 2024?
AbbVie Inc. annual long-term debt for 2024 was $60.34B, a 15.61% increase from 2023.
What was AbbVie Inc.'s long-term debt in 2023?
AbbVie Inc. annual long-term debt for 2023 was $52.19B, a 11.74% decline from 2022.
What is AbbVie Inc.'s 5-year long-term debt CAGR?
AbbVie Inc. long-term debt grew at a compound annual growth rate (CAGR) of 5.34% from FY2020 to FY2025, going from $77.55B to $58.94B over 5 years.
- Company
- AbbVie Inc.
- Ticker
- ABBV
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations